Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers

N. Shukla, M. F. Levine, G. Gundem, D. Domenico, B. Spitzer, N. Bouvier, J. E. Arango-Ossa, D. Glodzik, J. S. Medina-Martínez, U. Bhanot, J. Gutiérrez-Abril, Y. Zhou, E. Fiala, E. Stockfisch, S. Li, M. I. Rodriguez-Sanchez, T. O’Donohue, C. Cobbs, M. H. A. Roehrl, J. Benhamida, F. Iglesias Cardenas, M. Ortiz, M. Kinnaman, S. Roberts, M. Ladanyi, S. Modak, S. Farouk-Sait, E. Slotkin, M. A. Karajannis, F. Cruz, J. Glade Bender, A. Zehir, A. Viale, M. F. Walsh, A. L. Kung () and E. Papaemmanuil ()
Additional contact information
N. Shukla: Memorial Sloan Kettering Cancer Center
M. F. Levine: Memorial Sloan Kettering Cancer Center
G. Gundem: Memorial Sloan Kettering Cancer Center
D. Domenico: Memorial Sloan Kettering Cancer Center
B. Spitzer: Memorial Sloan Kettering Cancer Center
N. Bouvier: Memorial Sloan Kettering Cancer Center
J. E. Arango-Ossa: Memorial Sloan Kettering Cancer Center
D. Glodzik: Memorial Sloan Kettering Cancer Center
J. S. Medina-Martínez: Memorial Sloan Kettering Cancer Center
U. Bhanot: Memorial Sloan Kettering Cancer Center
J. Gutiérrez-Abril: Memorial Sloan Kettering Cancer Center
Y. Zhou: Memorial Sloan Kettering Cancer Center
E. Fiala: Memorial Sloan Kettering Cancer Center
E. Stockfisch: Memorial Sloan Kettering Cancer Center
S. Li: Memorial Sloan Kettering Cancer Center
M. I. Rodriguez-Sanchez: Memorial Sloan Kettering Cancer Center
T. O’Donohue: Memorial Sloan Kettering Cancer Center
C. Cobbs: Memorial Sloan Kettering Cancer Center
M. H. A. Roehrl: Memorial Sloan Kettering Cancer Center
J. Benhamida: Memorial Sloan Kettering Cancer Center
F. Iglesias Cardenas: Memorial Sloan Kettering Cancer Center
M. Ortiz: Memorial Sloan Kettering Cancer Center
M. Kinnaman: Memorial Sloan Kettering Cancer Center
S. Roberts: Memorial Sloan Kettering Cancer Center
M. Ladanyi: Memorial Sloan Kettering Cancer Center
S. Modak: Memorial Sloan Kettering Cancer Center
S. Farouk-Sait: Memorial Sloan Kettering Cancer Center
E. Slotkin: Memorial Sloan Kettering Cancer Center
M. A. Karajannis: Memorial Sloan Kettering Cancer Center
F. Cruz: Memorial Sloan Kettering Cancer Center
J. Glade Bender: Memorial Sloan Kettering Cancer Center
A. Zehir: Memorial Sloan Kettering Cancer Center
A. Viale: Memorial Sloan Kettering Cancer Center
M. F. Walsh: Memorial Sloan Kettering Cancer Center
A. L. Kung: Memorial Sloan Kettering Cancer Center
E. Papaemmanuil: Memorial Sloan Kettering Cancer Center

Nature Communications, 2022, vol. 13, issue 1, 1-15

Abstract: Abstract The utility of cancer whole genome and transcriptome sequencing (cWGTS) in oncology is increasingly recognized. However, implementation of cWGTS is challenged by the need to deliver results within clinically relevant timeframes, concerns about assay sensitivity, reporting and prioritization of findings. In a prospective research study we develop a workflow that reports comprehensive cWGTS results in 9 days. Comparison of cWGTS to diagnostic panel assays demonstrates the potential of cWGTS to capture all clinically reported mutations with comparable sensitivity in a single workflow. Benchmarking identifies a minimum of 80× as optimal depth for clinical WGS sequencing. Integration of germline, somatic DNA and RNA-seq data enable data-driven variant prioritization and reporting, with oncogenic findings reported in 54% more patients than standard of care. These results establish key technical considerations for the implementation of cWGTS as an integrated test in clinical oncology.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-022-30233-7 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30233-7

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-30233-7

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().